RBC has cut its rating on Dowlais Group PLC (LSE:DWL) from 'outperform' to 'sector perform', arguing that the US takeover by American Axle Manufacturing is now largely reflected in the share price. The bank has nudged up its price target to 77p, in line with the implied value of the all-share offer, leaving little room for upside from current levels.

T. Rowe Price US High Yield ETF (THYF) has preserved investor capital while providing better resilience during market declines. THYF offers a high starting dividend yield above 7% and pays out distributions on a monthly basis. Distributions have remained in a consistent range since inception, demonstrating the ETF's ability to provide reliable income for retirees.

Freeport-McMoRan cut copper costs sharply in Q2, but projects sequentially higher expenses ahead in Q3.

E teams up with GIP in a $100 trillion energy transition push, selling nearly half of its CCUS unit to scale carbon capture projects.

Intel (INTC) continues to gain traction. Jenny Horne explains the $2 billion investment from SoftBank and how it firms support for the American tech company.

23.6%. That's how much Intel's stock increased by last week, the best weekly performance by the company since January 2000.

Delray Beach, FL, Aug. 19, 2025 (GLOBE NEWSWIRE) -- According to MarketsandMarkets™, the Video Analytics Market is expected to grow from USD 8.3 billion by 2023 to USD 22.6 billion by 2028 at a Compound Annual Growth Rate (CAGR) of 22.3 % during the forecast period.

MONSEY, N.Y., Aug. 19, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Soho House & Co. Inc. (NYSE: SHCO) (“Soho”) for $9.00 per share in cash to an investor group led by MCR Hotels and its Chairman and CEO Tyler Morse.

Subscribers to Chart of the Week received this commentary on Sunday, August 17.

Key Points in This Article: Buffett's Q1 13-F filing revealed $3.9 billion in stock purchases, including six new positions, but he remains a net seller of stocks by shedding $7 billion in Apple and Bank of America holdings.

The crude oil markets look soft on Tuesday as we continue to see a lot of problems with the massive amount of supply being pumped into the markets are the moment. The market continues to look at the lack of demand as an issue as well.

CIB, TRTX and AB made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 19, 2025.

Netflix and Disney post strong earnings, boost guidance, and see upward estimate revisions on subscriber and revenue growth.

Newmont surges 85% YTD on gold price strength, rising earnings estimates, and solid cash flow, underscoring its growth potential.

IBM (NYSE:IBM) stock has declined 15% over the past month, lagging the S&P 500, which rose 2% over the same period. The slide largely reflects the latest quarterly report, where software segment sales came in below expectations.

Shares of Viking Therapeutics fell more than 30% on Tuesday after the company released mid-stage trial data on its obesity pill that disappointed investors. While the weight loss caused by Viking's pill was roughly comparable to that of other oral drugs, the side effects and discontinuation rates appeared to rattle Wall Street.

India's Russian oil imports declined in July after jumping the previous month as some refiners slowed purchases due to smaller discounts, while Indian fuel demand also typically dips during the monsoon season, according to trade sources and data.

-- Evofem now holds eleven Orange Book - listed patents covering SOLOSEC into late 2041 -- SAN DIEGO , Aug. 19, 2025 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCID: EVFM) today announced that a newly-issued U.S. patent which covers SOLOSEC® (secnidazole) 2 g oral granules and one of its labeled indications is now listed in the U.S. Food and Drug Administration (FDA) publication Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book. "The Orange Book listing of this patent covering SOLOSEC's method, pharmaceutical composition, and use in trichomoniasis is an important step in further strengthening our patent …

Palo Alto Networks, Inc. delivered a strong fiscal Q4 with beats on revenue and EPS, plus upbeat guidance for FY26, driving a post-earnings stock rebound. I remain bullish about PANW stock despite recent underperformance, and see the CyberArk acquisition and entry into identity security as a strategic long-term growth catalyst. The company's shift from hardware to software, strong ARR growth, and deepening customer platformization reinforce my conviction in durable, recurring revenue expansion.

Investors need to pay close attention to AAP stock based on the movements in the options market lately.